QA: Accustem Sciences Inc in us_pharma/2023

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001850767_2024_Accustem_Sciences_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}
warning Missing logo subcommand.report {}
warning Excluding company: variable exceeds outlier threshold pre-agg {'variable': 'Expenses', 'value': 1505102, 'size_variable': 'Assets', 'size_value': 50851, 'ratio': 29.6, 'threshold': 20}

Graph

Absolute values for 0001850767, Accustem Sciences Inc

  xvar xval
0 AssetsCurrent 129,849
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 4,048
3 remainder_Assets 0
4 LiabilitiesCurrent 2,245,477
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 1,911,001
9 ResearchAndDevelopmentExpense 139,663
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome 0
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 133,897
1 Liabilities 2,245,477
2 Expenses 2,050,664
3 Revenues 0
4 StockholdersEquity -2,111,580
5 NetIncome -2,050,664
6 ComprehensiveNetIncome -2,050,664
7 BaseVar 2,215,019
8 EconomicCapitalRatiobeforeLimitedLiability -5.59
9 EconomicCapitalRatio 0.115

Edgar->Model Mapping

Feature Distribution

Change over Time